HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

KICG1338

inhibits glycogen synthase kinase 3beta; structure in first source

Also Known As:

2-(4-fluorophenyl)-3H-imidazo(4,5-b)pyridine-7-carboxylic acid (4-methylpyridin-3-yl)amide

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Amines: 4871
  - Aminopyridines: 77
    - KICG1338: 1
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Imidazoles: 150
      - KICG1338: 1
  - Pyridines: 88
    - Aminopyridines: 77
      - KICG1338: 1

Experts

1.	Choi, Sung Hee: 1 article (07/2015)
2.	Durrance, Eunice Sung: 1 article (07/2015)
3.	Jang, Hak Chul: 1 article (07/2015)
4.	Jin, Hyunjin: 1 article (07/2015)
5.	Kim, Kyoung Min: 1 article (07/2015)
6.	Kim, Young-Bum: 1 article (07/2015)
7.	Lee, Gha Young: 1 article (07/2015)
8.	Lee, Kuy-Sook: 1 article (07/2015)
9.	Lim, Soo: 1 article (07/2015)
10.	Park, Ho Seon: 1 article (07/2015)

Related Diseases

1.	Insulin Resistance 07/05/2015 - "Anti-diabetic efficacy of KICG1338, a novel glycogen synthase kinase-3β inhibitor, and its molecular characterization in animal models of type 2 diabetes and insulin resistance."
2.	Type 2 Diabetes Mellitus (MODY) 07/05/2015 - "Anti-diabetic efficacy of KICG1338, a novel glycogen synthase kinase-3β inhibitor, and its molecular characterization in animal models of type 2 diabetes and insulin resistance."
3.	Inflammation (Inflammations) 07/05/2015 - "KICG1338 therapy also led to greater β-cell preservation and less hepatic fat infiltration with decreased expressions of genes involved in inflammation and endoplasmic reticulum stress. "

Related Drugs and Biologics

1.	Glycogen Synthase (Synthase I)

Related Therapies and Procedures

1.	Therapeutics